HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The aim of the study was to evaluate longitudinal associations between HbA 1c levels, diabetes status and subsequent cognitive decline over a 10 year follow-up period. Data from wave 2 (2004–2005) to wave 7 (2014–2015) of the English Longitudinal Study of Ageing (ELSA) were analysed. Cognitive function was assessed at baseline (wave 2) and reassessed every 2 years at waves 3–7. Linear mixed models were used to evaluate longitudinal associations. The study comprised 5189 participants (55.1% women, mean age 65.6 ± 9.4 years) with baseline HbA 1c levels ranging from 15.9 to 126.3 mmol/mol (3.6–13.7%). The mean follow-up duration was 8.1 ± 2.8 years and the mean number of cognitive assessments was 4.9 ± 1.5. A 1 mmol/mol increment in HbA 1c was significantly associated with an increased rate of decline in global cognitive z scores (−0.0009 SD/year, 95% CI −0.0014, −0.0003), memory z scores (−0.0005 SD/year, 95% CI −0.0009, −0.0001) and executive function z scores (−0.0008 SD/year, 95% CI −0.0013, −0.0004) after adjustment for baseline age, sex, total cholesterol, HDL-cholesterol, triacylglycerol, high-sensitivity C-reactive protein, BMI, education, marital status, depressive symptoms, current smoking, alcohol consumption, hypertension, CHD, stroke, chronic lung disease and cancer. Compared with participants with normoglycaemia, the multivariable-adjusted rate of global cognitive decline associated with prediabetes and diabetes was increased by −0.012 SD/year (95% CI −0.022, −0.002) and −0.031 SD/year (95% CI −0.046, −0.015), respectively ( p for trend <0.001). Similarly, memory, executive function and orientation z scores showed an increased rate of cognitive decline with diabetes. Significant longitudinal associations between HbA 1c levels, diabetes status and long-term cognitive decline were observed in this study. Future studies are required to determine the effects of maintaining optimal glucose control on the rate of cognitive decline in people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These tests have been shown to have high validity and reliability in the studies of others [16–18].”
From Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“4%] [14]) and/or diabetes are associated with accelerated cognitive decline in an elderly population with normal cognition at baseline; and (2) to examine whether people with diabetes with better glycaemic control, as measured by HbA1c levels, show a similar or decreased rate of subsequent cognitive decline.”
BackgroundThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Cohort profile: The English longitudinal study of ageing
Steptoe, A., Breeze, E., Banks, J., & Nazroo, J. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys168 · Cited by 1,779
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · cited 1×
“Although the underlying mechanisms remain to be elucidated, it is suggested that both hyperglycaemia and hypoglycaemia play important roles in diabetes-related cognitive decline [21, 22].”
BackgroundGlucose Levels and Risk of Dementia
Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215740 · Cited by 929 · cited 1×
“Genetic data are not available for the ELSA and so we cannot adjust for the APOE genotype; however, previous studies indicated that there is no interaction with APOE status and diabetes on cognitive decline [7, 8, 32].”
MethodThe incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
Diabetes and cognitive dysfunction
McCrimmon, R. J., Ryan, C. M., & Frier, B. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60360-2 · Cited by 880 · cited 1×
“Although the underlying mechanisms remain to be elucidated, it is suggested that both hyperglycaemia and hypoglycaemia play important roles in diabetes-related cognitive decline [21, 22].”
BackgroundRelation of diabetes to mild cognitive impairment
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.570 · Cited by 592 · cited 1×
“Genetic data are not available for the ELSA and so we cannot adjust for the APOE genotype; however, previous studies indicated that there is no interaction with APOE status and diabetes on cognitive decline [7, 8, 32].”
MethodLauner, L. J., Miller, M. E., Williamson, J. D., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M., Horowitz, K. R., Ding, J., Marcovina, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70188-0 · Cited by 574 · cited 2×
“No effect on cognitive decline was observed following an intervention to reduce HbA1c levels in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Memory in Diabetes Study (ACCORD-MIND) [25], while slower cognitive decline was observed following an intervention at an HbA1c level of 53.0 mmol/mol (7.0”
BackgroundInfluentialTrends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010
Selvin, E., Parrinello, C. M., Sacks, D. B., & Coresh, J. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2411 · Cited by 532 · cited 1×
“Diabetes, a metabolic disease characterised by hyperglycaemia that can lead to long-term dysfunction, has rapidly increased in prevalence over the past several decades [4, 5].”
BackgroundDementia: a global health priority - highlights from an ADI and World Health Organization report
Wortmann, M. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt143 · Cited by 471
Diabetes in Midlife and Cognitive Change Over 20 Years: A Cohort Study
Rawlings, A. M., Sharrett, A. R., Schneider, A. L. C., Coresh, J., Albert, M., Couper, D., Griswold, M., Gottesman, R. F., Wagenknecht, L. E., Windham, B. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0737 · Cited by 447 · cited 6×
“However, there is little research prospectively investigating the association of hyperglycaemia, based on HbA1c levels, with long-term cognitive decline in individuals with and without diabetes [12, 13].”
BackgroundResultInfluentialShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“Compared with individual fasting or post-load blood glucose measurements, HbA1c has better reliability between tests [10] because it reflects average circulating glucose levels over the preceding 2–3 months, making it a stronger predictor of subsequent diabetes [11].”
BackgroundMild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss
Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.411 · Cited by 364 · cited 1×
“could result in substantially greater cognitive decline over several years [31].”
BackgroundPoor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes
Punthakee, Z., Miller, M. E., Launer, L. J., Williamson, J. D., Lazar, R. M., Cukierman-Yaffee, T., Seaquist, E. R., Ismail-Beigi, F., Sullivan, M. D., Lovato, L. C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1855 · Cited by 337
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1117 · Cited by 313 · cited 1×
“Genetic data are not available for the ELSA and so we cannot adjust for the APOE genotype; however, previous studies indicated that there is no interaction with APOE status and diabetes on cognitive decline [7, 8, 32].”
MethodTuligenga, R. H., Dugravot, A., Tabák, A. G., Elbaz, A., Brunner, E. J., Kivimäki, M., & Singh-Manoux, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70192-x · Cited by 211 · cited 6×
“However, there is little research prospectively investigating the association of hyperglycaemia, based on HbA1c levels, with long-term cognitive decline in individuals with and without diabetes [12, 13].”
BackgroundResultInfluentialDregan, A., Stewart, R., & Gulliford, M. C. (2013) · Age and Ageing · doi:10.1093/ageing/afs166 · Cited by 195 · cited 1×
“The task is well documented to be both reliable and valid, and has previously been used as an indicator of executive function for the ELSA population [18].”
MethodCognition in the Early Stage of Type 2 Diabetes
Ruis, C., Biessels, G. J., Gorter, K. J., van den Donk, M., Kappelle, L. J., & Rutten, G. E. H. M. (2009) · Diabetes Care · doi:10.2337/dc08-2143 · Cited by 164 · cited 1×
“Modest cognitive function decrements are already present during the early stage of diabetes [28], and the effects of tight glycaemic control on those with established diabetes are complicated and yet to be determined.”
BackgroundMild Cognitive Impairment, Dementia, and Their Subtypes in Oldest Old Women
Yaffe, K., Middleton, L. E., Lui, L.-Y., Spira, A. P., Stone, K., Racine, C., Ensrud, K. E., & Kramer, J. H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.82 · Cited by 123
Predictive Value of Mild Cognitive Impairment for Dementia
Baars, M. A. E., van Boxtel, M. P. J., Dijkstra, J. B., Visser, P. J., van den Akker, M., Verhey, F. R. J., & Jolles, J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000200465 · Cited by 87 · cited 1×
“Immediate and delayed recall tests have been shown to have good construct validity and consistency [17].”
BackgroundImproved diabetes control in the elderly delays global cognitive decline
Luchsinger, J. A., Palmas, W., Teresi, J. A., Silver, S., Kong, J., Eimicke, J. P., Weinstock, R. S., & Shea, S. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0057-x · Cited by 84 · cited 1×
“0%) or less in the Informatics in Diabetes Education and Telemedicine Study (IDEATel) [26].”
BackgroundKoekkoek, P. S., Ruis, C., van den Donk, M., Biessels, G. J., Gorter, K. J., Kappelle, L. J., & Rutten, G. E. H. M. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.028 · Cited by 65
English Longitudinal Study of Ageing: Waves 0-7, 1998-2015
Marmot, M. (2017) · UK Data Archive · doi:10.5255/ukda-sn-5050-14 · Cited by 8
Research works printed but not linked: 1
- Graig R Deverill C Pickering K Spronston K Mindell J Quality control of blood saliva and urine analytes Health Survey for England 2004: methodology and documentation 2006 London The Information Centre
Cited by
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715
Association between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535
Self-citationCognitive Decline Before and After Incident Coronary Events
Xie, W., Zheng, F., Yan, L., & Zhong, B. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.019 · Cited by 279
Self-citationThe Impact of Disease Comorbidities in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259
“For example, HbAc1, a measure of average blood glucose level, has been positively associated with the increased risk of cognitive decline and dementia in several studies (Yaffe et al., 2006; Rawlings et al., 2017; Zheng et al., 2018).”
BackgroundAssociation of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality
Li, C., Zhu, Y., Ma, Y., Hua, R., Zhong, B., & Xie, W. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.045 · Cited by 233
Self-citation
Metadata
- Authors
- Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W.
- Affiliations
- Chinese Academy of Sciences (CN)
- Imperial College London (GB)
- Peking University (CN)
- Corresponding author
- Xie, Wuxiang
- Venue
- Diabetologia
- Published
- 2018-01-25
- Volume
- 61
- Issue
- 4
- Pages
- 839-848
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC6448974
- OpenAlex
- W2791177277
- Cited by
- 280
- References
- 32
- Citations by year
- 2026: 31 · 2025: 54 · 2024: 35 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 24 · 2019: 24 · 2018: 13
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Academy of Medical Sciences (P56804)
- National Natural Science Foundation of China (81601176)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- HbA1c, diabetes mellitus, prediabetes, cognitive decline, memory, executive function, older adults, English Longitudinal Study of Ageing, glycemic control, dementia risk, HbA1c thresholds, cognitive function trajectories, HbA1c trajectories, diabetes subtypes
- MeSH terms
- Aged, Blood Glucose, Cognition, Cross-Sectional Studies, Diabetes Mellitus, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Memory, Middle Aged, Reproducibility of Results, Treatment Outcome, Diabetes Complications, Executive Function, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.